Home > Healthcare > Biotechnology > Biopharma > Pharmacogenomics Market

Pharmacogenomics Market Share

Report ID: GMI9535
Published Date: May 2024
Report Format: PDF

Download Free Sample

Pharmacogenomics Market Share

The pharmacogenomics industry is characterized by intense competition, with companies focusing on innovation, product differentiation, and strategic collaborations to gain a competitive edge. Growing adoption of pharmacogenomics in clinical practice, coupled with advancements in genomic technologies and increasing investment in research and development, is expected to drive further competition and innovation in the market. Overall, the market presents lucrative opportunities for companies to capitalize on the growing demand for personalized medicine and genetic testing in healthcare.

Pharmacogenomics Market Companies

Prominent players operating in the pharmacogenomics industry include:

Agilent Technologies Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Charles River Laboratories
Danaher Corporation
Eurofins Scientific
F. Hoffmann-La Roche Ltd
Illumina Inc.
Laboratory Corporation of America Holdings
Mesa Labs, Inc.
Novogene Co., Ltd.
Revvity
Qiagen N.V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of pharmacogenomics reached USD 3.3 billion in 2023 and is set to witness 10.5% CAGR during 2024-2032, led by increasing demand for precision medicine and advancements in genomic technologies.

The kits & reagents offering segment recorded USD 2 billion in 2023, as they offer a diverse portfolio of products tailored to different pharmacogenomics applications and technologies.

North America market size was valued at USD 1.3 billion in 2023 and is anticipated to grow at 10.4% CAGR during 2024-2032, owing to robust healthcare infrastructure, with advanced research facilities and leading academic institutions.

Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Charles River Laboratories, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd, and Illumina Inc. among others.